1-4 of 4
Laura J. Johnston
Close
Sort by
Journal Articles

Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD

Clinical Trials & Observations
Cameron S. Bader, Anna Pavlova, Robert Lowsky, Lori S. Muffly, Parveen Shiraz, Sally Arai, Laura J. Johnston, Andrew R. Rezvani, Wen-Kai Weng, David B. Miklos, Matthew J. Frank, John S. Tamaresis, Vaibhav Agrawal, Sushma Bharadwaj, Surbhi Sidana, Judith A. Shizuru, Nathaniel B. Fernhoff, Amy Putnam, Scott Killian, Bryan J. Xie, Robert S. Negrin, Everett H. Meyer
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1105–1115.
https://doi.org/10.1182/bloodadvances.2023011625
Published: 2024
Includes: Supplemental data
Journal Articles

Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Vandana Sundaram, Connie Chen, Ilana Yurkiewicz, Eric Kuo, Sarah Burnash, Jay Y. Spiegel, Sally Arai, Matthew J. Frank, Laura J. Johnston, Robert Lowsky, Everett H. Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Parveen Shiraz, Judith A. Shizuru, Wen-Kai Weng, Michaela Liedtke, Hyma T. Vempaty, David B. Miklos
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3147–3151.
https://doi.org/10.1182/bloodadvances.2021004234
Published: 2021
Includes: Supplemental data
Journal Articles

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

Clinical Trials & Observations
Michael A. Spinner, Vanessa E. Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Wen-Kai Weng, Richard T. Hoppe, Samuel Strober, Robert Lowsky
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2454–2464.
https://doi.org/10.1182/bloodadvances.2019000297
Published: 2019
Includes: Supplemental data
Journal Articles

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Clinical Trials & Observations
Michael A. Spinner, Marcelo Fernández-Viña, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Judith A. Shizuru, Wen-Kai Weng, Ginna G. Laport, Samuel Strober, Robert Lowsky, Andrew R. Rezvani
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1347–1357.
https://doi.org/10.1182/bloodadvances.2017007716
Published: 2017
Includes: Supplemental data